Neoadjuvant chemotherapy for resectable adenocarcinoma of the panctreatic head - a prospective phase II trial

被引：0
作者：
Pestalozzi, B. C. [1 ]
Heinrich, S. [1 ]
Schafer, M. [1 ]
Pierre-Alain, C. [1 ]
机构：
[1] Univ Hosp Zurich, Zurich, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4610
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Factors associated with Failure to Reach Surgical Resection in Patients undergoing Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma
    Gleisner, A. L.
    Miller, J. L.
    Assifi, M.
    Steve, J. Y.
    Bartlett, D. L.
    Hogg, M. E.
    Zeh, H. J.
    Zureikat, A. H.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S177 - S177
  • [32] Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
    van den Ende, Tom
    de Clercq, Nicolien C.
    Henegouwen, Mark I. van Berge
    Gisbertz, Suzanne S.
    Geijsen, E. D.
    Verhoeven, R. H. A.
    Meijer, Sybren L.
    Schokker, Sandor
    Dings, M. P. G.
    Bergman, Jacques J. G. H. M.
    Mohammad, Nadia Haj
    Ruurda, Jelle P.
    van Hillegersberg, Richard
    Mook, Stella
    Nieuwdorp, Max
    de Gruijl, Tanja D.
    Soeratram, Tanya T. D.
    Ylstra, Bauke
    van Grieken, Nicole C. T.
    Bijlsma, Maarten F.
    Hulshof, Maarten C. C. M.
    van Laarhoven, H. W. M.
    CLINICAL CANCER RESEARCH, 2021, 27 (12) : 3351 - 3359
  • [33] A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma
    Paiella, Salvatore
    Malleo, Giuseppe
    Simoni, Nicola
    Micera, Renato
    Guariglia, Stefania
    Cavedon, Carlo
    Marchegiani, Giovanni
    Esposito, Alessandro
    Landoni, Luca
    Casetti, Luca
    Tuveri, Massimiliano
    Milella, Michele
    Secchettin, Erica
    Manzini, Gessica
    Bovo, Chiara
    De Pastena, Matteo
    Fontana, Martina
    Salvia, Roberto
    Mazzarotto, Renzo
    Bassi, Claudio
    BMC CANCER, 2021, 21 (01)
  • [34] A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma
    Salvatore Paiella
    Giuseppe Malleo
    Nicola Simoni
    Renato Micera
    Stefania Guariglia
    Carlo Cavedon
    Giovanni Marchegiani
    Alessandro Esposito
    Luca Landoni
    Luca Casetti
    Massimiliano Tuveri
    Michele Milella
    Erica Secchettin
    Gessica Manzini
    Chiara Bovo
    Matteo De Pastena
    Martina Fontana
    Roberto Salvia
    Renzo Mazzarotto
    Claudio Bassi
    BMC Cancer, 21
  • [35] A phase II trial of preoperative chemotherapy and chemoradiotherapy for potentially resectable adenocarcinoma of the stomach (RTOG 99-04)
    Okawara, GS
    Winter, K
    Donohue, JH
    Pisters, PWT
    Crane, CH
    Greskovich, JF
    Anne, PR
    Bradley, JD
    Willet, C
    Ajani, JA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 312S - 312S
  • [36] Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma
    Eid, Michal
    Ostrizkova, Lenka
    Kunovsky, Lumir
    Brancikova, Dagmar
    Kala, Zdenek
    Hlavsa, Jan
    Janecek, Pavel
    Kosikova, Ivana
    Blazkova, Monika
    Slaby, Ondrej
    Mayer, Jiri
    NEOPLASMA, 2021, 68 (01) : 1 - 9
  • [37] Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer
    Kharofa, Jordan
    Mierzwa, Michelle
    Olowokure, Olugbenga
    Sussman, Jeffrey
    Latif, Tahir
    Gupta, Anumeha
    Xie, Changchun
    Patel, Sameer
    Esslinger, Hope
    Mcgill, Brian
    Wolf, Eric
    Ahmad, Syed A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (03): : 247 - 252
  • [38] Neoadjuvant chemotherapy is superior to adjuvant treatment in resectable pancreatic adenocarcinoma
    Artinyan, A.
    Anaya, D.
    Mailey, B.
    Ellenhorn, J. D.
    Kim, J.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S80 - S81
  • [39] Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma
    Sugawara, Toshitaka
    Rodriguez Franco, Salvador
    Sherman, Samantha
    Torphy, Robert
    Colborn, Kathryn
    Franklin, Oskar
    Ishida, Jun
    Grandi, Samuele
    Al-Musawi, Mohammed
    Gleisner, Ana
    Schulick, Richard
    Del Chiaro, Marco
    ANNALS OF SURGERY, 2024, 279 (02) : 331 - 339
  • [40] A randomized phase II trial of neoadjuvant chemotherapy compared with chemoradiotherapy in locally advanced gastroesophageal and gastric adenocarcinoma
    Jin, J.
    Wang, X.
    Zhao, D. B.
    Chi, Y.
    Zhao, H.
    Yang, L.
    Zhou, A. P.
    Jiang, L. M.
    Tang, Y.
    Ren, H.
    Li, N.
    Liu, W. Y.
    Li, Y. X.
    ANNALS OF ONCOLOGY, 2015, 26 : 69 - 69
12345